Clinical Trial Update: Thymalfasin and Recombinant Human IL-2 Injections in Treating Lymphocytopenia for Patients With Malignant Hematological Tumors [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating thymalfasin and recombinant human interleukin-2 injections for lymphocytopenia in patients with malignant hematological tumors. The t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematological Malignancy
• Lymphocytopenia

Drugs mentioned

• Recombinant human interleukin-2 (interleukin-2)
• Thymalfasin (thymosin alpha-1)

Snippet

Sponsor: The First Affiliated Hospital of Xiamen University | Conditions: Hematological Malignancy, Lymphocytopenia | Phase 2 | Status: RECRUITING